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Abstract 
Using directed evolution, a variant N-acetyl amino acid racemase (NAAAR G291D/F323Y) has been 
developed with up to five fold higher activity than the wild-type on a range on N-acetylated amino 
acids. The variant has been coupled with an enantiospecific acylase to give agram scale dynamic 
kinetic resolution which allows 89% conversion of N-acetyl-DL-allylglycine into D-allylglycine in 18 
hours at suitably high substrate concentrations for industrial use (50 g L
-1
). This is the first example of 
NAAAR operating under conditions which would allow it to be successfully used on an industrial 
scale for the production of enantio-pure α-amino acids. X-ray crystal analysis of the improved 
NAAAR variant allowed a comparison with the wild-type enzyme. We postulate that a network of 
novel interactions that result from the introduction of the two side-chains is the source of improved 
catalytic performance. 
 
Introduction 
Kinetic resolutions (KRs) that employ stereo-selective acylases are commonly used for the production 
of both L- and D- α-amino acids from their N-acetylated-DL- starting materials.1-4 However, a 
drawback in this process is the need for repeated chemo-catalytic racemisation steps of the non-
desired enantiomer to achieve yields >50% (Scheme 1a). These racemisation steps, if performed at all, 
are typically implemented under harsh chemical conditions resulting in extra cost and waste. A 
solution to this problem would be a dynamic kinetic resolution (DKR), driven by an in situ 
racemisation step that would allow yields to approach 100% (Scheme 1b). A cheap and “green” 
catalyst for this racemisation would be an enzyme, such as N-acyl amino acid racemase (NAAAR) 
from the actinobacterium Amycolatopsis sp. Ts-1-60. This enzyme has many desirable features in that 
it requires no organic cofactor, is active at high temperatures, accepts a wide range of amino acid 
substrates and suffers no substrate or product inhibition up to 300 mM. Unfortunately, the activity of 
NAAAR with the desired N-acetyl substrates is too low for commercial use. To amend this, we have 
used directed evolution to generate NAAAR variants with increased racemase activity towards N-
acetyl amino acids. Directed evolution has proven to be a highly versatile and successful tool for 
protein engineering.5-8 However, finding improved enzymes is often technically difficult or time 
consuming due to the large number of variants that must be screened. In the case of NAAAR this is 
especially true; the substrate and product are enantiomers which makes assay development difficult. 
To overcome this, we have generated an enantioselective genetic selection system that allows for 
high-throughput screening of mutagenic NAAAR libraries. 
NAAAR activity has been detected in Streptomyces atratus Y-53, many Amycolatopsis species and 
more recently in several thermophiles.
9-14
 In these bacteria, NAAAR is believed to act as a bi-
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functional enzyme. Firstly, as an o-succinyl benzoate synthase (OSBS) that catalyses the formation of 
o-succinylbenzoate (a precursor of menaquinone) from 2-hydroxy-6-succinyl-2,4-cyclohexadiene 
carboxylate (Scheme 1c)
15
, and secondly as the racemase in a three-step D-amino acid detoxification 
pathway. This pathway is suggested to involve a D-specific N-succinyl transferase, an N-succinyl-
amino acid racemase (Scheme 1d), followed by a L-specific N-succinyl amino acid hydrolase which 
together racemise D-amino acids.
16
 NAAAR has been well studied as a member of the enolase 
superfamily, and enzymatic analysis has shown that the NAAAR reaction proceeds via a divalent 
cation-dependent, enolate-based proton transfer catalysed by two lysine residues.
17
 The racemization 
of N-succinyl amino acids (and the OSBS reaction) is known to be ~20 fold-faster than with the 
equivalent N-acetylated amino acids. As the present acylase process for the production of enantio-
pure α-amino acids requires N-acetylated substrates, high activity towards these amino acid 
derivatives is essential. If a NAAAR variant could be isolated with sufficiently high activity, the 
current acylase KR process could be run as a coupled NAAAR/acylase DKR which would almost 
double the final yield of product. 
 
Scheme 1. a) A D-acylase-based resolution of an N-acetyl-DL-amino acid to yield an enantiopure D-
amino acid; b) a NAAAR/acylase coupled dynamic kinetic resolution. The two natural reactions of 
the OSBS/NAAAR protein; c) as an OSBS in the menaquinone pathway, d) as an N-succinyl amino 
acid racemase. 
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Enantioselective selection method 
To efficiently screen mutagenic NAAAR libraries, a selection method was required that linked the 
rate of racemisation of an N-acetyl amino acid to the viability of an Escherichia coli (E. coli) host. 
This has been achieved by disabling the natural E. coli L-methionine biosynthetic pathway, and at the 
same time removing a D-amino acid racemization pathway (Scheme 2). Conversion of L-homoserine 
to L-methionine was abolished by deletion of the second enzyme in the L-methionine biosynthetic 
pathway, cystathionine γ-synthase (metB), while D-amino acid racemization was prevented by 
deletion of a non-specific D-amino acid dehydrogenase (dadA). DadA combines with an 
aminotransferase to racemise a variety of amino acids via their pro-chiral keto acid allowing toxic D-
amino acids to act as a source of useful L-amino acids. As a result of these deletions, when grown in 
minimal media containing N-acetyl-D-methionine as the sole methionine source, the selection host is 
now dependent on recombinant NAAAR activity to racemise this to N-acetyl-L-methionine. An 
endogenous hydrolase then provides the source of L-methionine from the N- acetylated substrate. 
Using the λ-red mediated gene replacement/deletion method, dadA was deleted and metB replaced 
with a chloramphenicol resistance gene.18 This double-knock out host, named SET21, is now 
completely unable to synthesize L-methionine or racemise D-methionine. Importantly, the SET21 
host is viable on N-acetyl-L-methionine allowing for a NAAAR-dependent screening method shown 
in Scheme 2. The ability of NAAAR to complement the SET21 strain and produce viable colonies 
was confirmed by transformation of SET21 with a plasmid expressing NAAAR wild type (WT) and 
selection on minimal media supplemented with N-acetyl-D-methionine as the sole methionine source 
(see supporting information). 
 
← Scheme 2. Disabled L-methionine 
biosynthesis in E. coli SET21 host and 
NAAAR-dependent growth on N-
acetyl-D-methionine.  
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Directed evolution 
Using the SET21 selection host, mutagenic libraries of the Amycolatopsis sp. Ts-1-60 NAAAR gene 
were screened and the best variant used as the template for the next round of mutagenesis/selection. 
Variants were generated using XL1-Red (>10
7
 variants), error prone PCR (>10
5
 variants) and 
saturation mutagenesis (>10
2
 variants). Active variants were selected by SET21 colony size when 
grown on minimal media supplemented with N-acetyl-D-methionine or by high throughput HPLC 
screening. Selection of libraries generated by XL1-Red mutagenesis highlighted the G291E mutation, 
which was subsequently improved upon by saturation mutagenesis to generate G291D. Error prone 
PCR on this clone generated NAAAR G291D F323Y which could not be improved upon after 
saturation mutagenesis of F323Y and a further round of error prone PCR. Saturation mutagenesis of 
other residues (D316 and S135) within the active site of NAAAR G291D F323Y failed to generate 
improved variants. 
The NAAAR activity of each variant was determined by expression and purification of recombinant 
protein followed by kinetic analysis with a range of amino acids. The rate of racemisation was 
monitored with chiral HPLC and the activities of the best variant from each round of selection are 
shown in Table 1. Gratifyingly, the NAAAR G291D F323Y variant displayed the most improved 
activity with each of the substrates tested, showing ~2- to 6-fold improved Kcat values. The kinetic 
data would suggest that the mutations are directly affecting turnover and not binding as no major 
change in Km was observed. 
 
 
Table 1. Whole cell biotransformations of NAAAR variants with various N-acetylated amino acids. 
 
NAAAR/acylase DKRs 
To measure the improvement in the DKR of N-acetyl-DL-amino acids with these variant NAAARs, 
small scale resolutions were performed using whole cell biocatalysts expressing an L-acylase and one 
 
 
N-acetylated amino acid substrate 
L-methionine D-methionine D-(4-
fluoro)phenylglycine 
D-allylglycine 
variant kcat (s
-1) Km 
(mM) 
kcat (s
-1) Km (mM) kcat (s
-1) Km (mM) kcat (s
-1) Km 
(mM)* 
WT 20 18 14 40 41 35 97 N.D 
G291E 48 40 27 40 103 35 125 N.D 
G291D 80 40 54 40 125 35 153 N.D 
G291D 
F323Y 
95 40 67 50 272 40 232 N.D 
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of NAAAR WT, G291E, G291D, or G291D F323Y. Combinations of the acylase and NAAAR hosts 
were mixed, and the resolution of N-acetyl-DL-methionine to L-methionine monitored over five hours 
by chiral HPLC (Figure 1). As expected, with no NAAAR present, N-acetyl-D-methionine showed no 
conversion to free L-methionine (data not shown). When BL21(DE3) cells expressing NAAAR WT 
were used, N-acetyl-D-methionine was now a substrate, via racemisation, for the L-specific acylase, 
however, the rate of racemization (krac) was clearly slower than the rate of hydrolysis (khyd) (Figure 
1a). Similar results, with improved krac values were observed for both G291 variants; however krac was 
still slower than khyd (data not shown). Encouragingly, in reactions containing BL21(DE3) expressing 
NAAAR G291D F323Y, both enantiomers of N-acetyl-methionine were being consumed at the same 
rate, i.e. krac ≥ khyd (Figure 1b). This suggests that with NAAAR G291D F323Y, the process runs as an 
effective DKR. The ee of the final L-methionine was >99% (by chiral HPLC). 
The performance of NAAAR G291D F323Y under process-like conditions was further investigated 
with a DKR of N-acetyl-DL-allylglycine using a partially purified NAAAR G291D F323Y biocatalyst 
generated from an E. coli fermentation (see Supporting Information). A coupled NAAAR G291D 
F323Y/D-acylase process was used to resolve 1g N-acetyl-DL-allylglycine to D-allylglycine with 
>89% yield (by isolated product) in 18 hours. Greater than 98% conversion was recorderd by HPLC 
trace. The equivalent D-acylase kinetic resolution would give only a theoretical maximum of 50% 
conversion. Similar results were observed for other amino acids (data not shown). The low enzyme 
loading required and excellent yields suggest these processes would be economical at scale.  
 
NAAAR G291D F323Y structure 
Analysis of the wild-type NAAAR:N-acetyl-methionine structure (PDB code: 1SJA) revealed that 
both G291 and F323 are found within the N-acyl binding pocket, 5-6 Å from the substrate acyl 
group.
19
 To gain an insight into the molecular basis for the improvement in catalysis, the X-ray crystal 
structure of NAAAR G291D F323Y (PDB code: 4A6G) was determined. A dataset to a resolution of 
2.71 Å was collected, and the structure solved using 1SJA as a model (see supporting information). 
Two novel interactions were observed that could be attributed to the G291D and F323Y mutations 
(Figure 2a). These are a salt bridge between the carboxylate of D291 and the guanidinium of R299 
(2.7 Å), and an H-bonding interaction between the carboxylate of D291, and the hydroxyl of Y323 
(2.8 Å). The resolution of the structure prevented identification of definitive changes in protein-ligand 
interactions; however, the ligand was slightly displaced compared to the published WT structure, 
suggesting that its binding environment had been altered. 
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Figure 1. DKR of N-acetyl-DL-methionine by the coupled NAAAR/L-acylase process with a) 
NAAAR WT and b) NAAAR G291D F323Y. The decrease in N-acetyl-D-methionine concentration 
gives a measure of racemase activity (krac), and the drop in N-acetyl-L-methionine gives a measure of 
acylase activity (khyd). No major increase in L-methionine yield is observed as the reaction has not 
gone to completion and is limited by L-acylase turnover. 
 
The most interesting observation can be made when comparing the structures of NAAAR WT 
complexed with N-succinyl-methionine (PDB code: 1SJC)
19
 and NAAAR G291D F323Y complexed 
with N-acetyl-methionine. Here, the carboxylate of G291D can be seen to be mimicking the succinyl 
carboxylate which is not present on the acetyl group. As NAAAR WT is 10-20 fold more active with 
N-succinyl amino acids than the equivalent N-acetyl substrates, it appears this interaction is of key 
importance for efficient turnover. In the NAAAR WT:N-succinyl methionine structure this interaction 
is made via two structural water molecules (Figure 2b). These observations are complemented by 
kinetic data that suggest that protein:ligand binding has not been dramatically affected with 
introduction of the G291D and F323Y mutations. 
 
Page 7 of 10 
 
Figure 2. a) New interactions observed in the NAAAR G291D F323Y acyl binding pocket, NAM = 
N-acetyl-methionine. b) Interactions between succinyl carboxylate and R299 via two water molecules 
(red spheres), NSM = N-succinyl-methionine.  
 
In summary, a variant NAAAR with increased activity towards a variety of synthetically useful N-
acetyl amino acids has been evolved that shows promise as an industrial biocatalyst. When coupled 
with a stereo-selective acylase, gram level resolutions with excellent yields could be achieved within 
18h at 50 g L-1 substrate concentrations. Initial results would suggest these processes will be cost 
effective at scale for the production of a range of both proteinogenic and non-proteinogenic α-amino 
acids. 
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